AtonRa Partners - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 306 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.

Quarter-by-quarter ownership
AtonRa Partners ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$423,163
-11.4%
9,329
-19.8%
0.89%
+20.0%
Q2 2023$477,425
+8.2%
11,636
-5.7%
0.74%
+14.8%
Q1 2023$441,175
-15.8%
12,344
-11.0%
0.64%
-3.6%
Q4 2022$524,059
-32.8%
13,875
-21.3%
0.67%
-12.8%
Q3 2022$780,000
+16.1%
17,628
-2.9%
0.77%
+23.9%
Q2 2022$672,000
-25.8%
18,146
-9.9%
0.62%
+53.0%
Q1 2021$906,000
+105.0%
20,146
+157.7%
0.40%
+86.2%
Q4 2020$442,0007,8170.22%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Bellevue Group AG 9,930,245$396,117,0003.87%
Sicart Associates LLC 368,409$14,696,0003.50%
Camber Capital Management LP 2,000,000$79,780,0002.69%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 181,781$7,251,0001.91%
SECTOR GAMMA AS 263,488$10,511,0001.86%
Parkman Healthcare Partners LLC 136,380$5,440,0001.19%
Eversept Partners, LP 442,000$17,631,3801.18%
Affinity Asset Advisors, LLC 75,000$2,992,0001.07%
TANAKA CAPITAL MANAGEMENT INC 16,661$665,0000.90%
Sonora Investment Management, LLC 168,665$6,728,0000.88%
View complete list of IONIS PHARMACEUTICALS INC shareholders